This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Harrison CJ, Martineau M, Secker-Walker LM . The Leukaemia Research Fund/United Kingdom Cancer Cytogenetics Group Karyotype Database in acute lymphoblastic leukaemia: a valuable resource for patient management. Br J Haematol 2001; 113: 3–10.
Crossen PE, Savage LM, Heaton DC, Morrison MJ . Characterization of the C-MYC amplicon in a case of acute myeloid leukemia with double minute chromosomes. Cancer Genet Cytogenet 1999; 112: 144–148.
Cuthbert G, Thompson K, McCullough S, Watmore A, Dickinson H, Telford N et al MLL amplification in acute leukaemia: a United Kingdom Cancer Cytogenetics Study Group (UKCCG) study. Leukemia 2000; 14: 1885–1891.
Sait SN, Qadir MU, Conroy JM, Matsui S, Nowak NJ, Baer MR . Double minute chromosomes in acute myeloid leukemia and myelodysplastic syndrome: identification of new amplification regions by fluorescence in situ hybridization and spectral karyotyping. Genes Chromosomes Cancer 2002; 34: 42–47.
Harewood L, Robinson H, Harris R, Jabbar Al-Obaidi MS, Jalali GR, Martineau M et al Amplification of AML1 on a duplicated chromosome 21 in acute lymphoblastic leukemia: a study of 20 cases. Leukemia 2003; 17: 547–553.
Campbell LJ, Patsouris C, Rayeroux KC, Somana K, Januszewicz EH, Szer J . BCR/ABL amplification in chronic myelocytic leukemia blast crisis following imatinib mesylate administration. Cancer Genet Cytogenet 2002; 139: 30–33.
Morel F, Bris MJ, Herry A, Calvez GL, Marion V, Abgrall JF et al Double minutes containing amplified bcr-abl fusion gene in a case of chronic myeloid leukemia treated by imatinib. Eur J Haematol 2003; 70: 235–239.
Collins SJ, Groudine MT . Rearrangement and amplification of c-abl sequences in the human chronic myelogenous leukemia cell line K-562. Proc Natl Acad Sci USA 1983; 80: 4813–4817.
Kenner L, Beham-Schmid C, Kerbl R, Schmidt HH, Sill H, Hoefler G . ABL amplification in a patient with lymphoid blast crisis of chronic myelogenous leukaemia. Virchows Arch 1999; 434: 255–257.
Tanaka K, Arif M, Eguchi M, Kyo T, Dohy H, Kamada N . Frequent jumping translocations of chromosomal segments involving the ABL oncogene alone or in combination with CD3-MLL genes in secondary leukemias. Blood 1997; 89: 596–600.
ISCN. An International System for Human Cytogenetic Nomenclature, 1st edn. Basel: S Karger, 1995.
Vaillant F, Blyth K, Terry A, Bell M, Cameron ER, Neil J et al. A full-length Cbfa1 gene product perturbs T-cell development and promotes lymphomagenesis in synergy with myc. Oncogene 1999; 18: 7124–7134.
Mao X, Lillington D, Child F, Russell-Jones R, Young B, Whittaker S . Comparative genomic hybridization analysis of primary cutaneous B-cell lymphomas: identification of common genomic alterations in disease pathogenesis. Genes Chromosomes Cancer 2002; 35: 144–155.
Mao X, Onadim Z, Price EA, Child F, Lillington DM, Russell-Jones R et al Genomic alterations in blastic natural killer/extranodal natural killer-like T cell lymphoma with cutaneous involvement. J Invest Dermatol 2003; 121: 618–627.
Mao X, Orchard G, Lillington DM, Russell-Jones R, Young BD, Whittaker S . Genetic alterations in primary cutaneous CD30+ anaplastic large cell lymphoma. Genes Chromosomes Cancer 2003; 37: 176–185.
Jack EM, Harrison CJ, Allen TD, Harris R . A scanning electron microscope study of double minutes from a human tumour cell line. Cytogenet Cell Genet 1987; 44: 49–52.
Von Hoff DD, Needham-VanDevanter DR, Yucel J, Windle BE, Wahl GM . Amplified human MYC oncogenes localized to replicating submicroscopic circular DNA molecules. Proc Natl Acad Sci USA 1988; 85: 4804–4808.
Maurer BJ, Lai E, Hamkalo BA, Hood L, Attardi G . Novel submicroscopic extrachromosomal elements containing amplified genes in human cells. Nature 1987; 327: 434–437.
Acknowledgements
We thank the Leukaemia Research Fund for financial support and the following UKCCG laboratories for providing samples for this study: Glasgow, Leeds, Leicester, Manchester, Nottingham, Cambridge, Salisbury and Oxford. We are also grateful to Dr M Rocchi (Resources in Molecular Cytogenetics, Bari, Italy) for kindly donating the ABL-specific PAC probes and to Dr John Crolla (Wessex Regional Genetics Laboratories, Salisbury) for growing and preparing these PAC probes as part of an ongoing collaborative study. This study could not have been performed without the dedication of the members of Medical Research Council Adult and Childhood Leukaemia Working Parties, who have designed and coordinated the clinical trials through which these patients were identified and on which they were treated.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Barber, K., Martineau, M., Harewood, L. et al. Amplification of the ABL gene in T-cell acute lymphoblastic leukemia. Leukemia 18, 1153–1156 (2004). https://doi.org/10.1038/sj.leu.2403357
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2403357
This article is cited by
-
Developing Targeted Therapies for T Cell Acute Lymphoblastic Leukemia/Lymphoma
Current Hematologic Malignancy Reports (2023)
-
Philadelphia Chromosome Positive Pre-T Cell Acute Lymphoblastic Leukemia: A Rare Case Report and Short Review
Indian Journal of Hematology and Blood Transfusion (2014)
-
Six Cases of Rare Gene Amplifications and Multiple Copy of Fusion Gene in Childhood Acute Lymphoblastic Leukemia
Pathology & Oncology Research (2013)
-
Rapid complete cytogenetic remission after upfront dasatinib monotherapy in a patient with a NUP214-ABL1-positive T-cell acute lymphoblastic leukemia
Leukemia (2009)
-
Heterogeneous patterns of amplification of the NUP214-ABL1 fusion gene in T-cell acute lymphoblastic leukemia
Leukemia (2009)